What is SYRA stock price today?

Visit our real-time dashboard for the current SYRA stock price and live market data.

Is SYRA stock going up or down today?

SYRA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SYRA stock now?

The decision to buy SYRA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SYRA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SYRA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SYRA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SYRA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SYRA's P/E ratio?

P/E ratio data for SYRA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SYRA's market cap?

SYRA (Syra Health Corp. Class A Common Stock) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is SYRA's price to book ratio?

Price-to-book ratio for SYRA is available on our dashboard along with other valuation metrics.

Does SYRA pay dividends?

SYRA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SYRA's dividend yield?

SYRA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SYRA stock a good long-term investment?

SYRA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SYRA's revenue growth rate?

Revenue growth data for SYRA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for SYRA are available on our dashboard with complete income statement analysis.

What are the risks of investing in SYRA?

Key risks for SYRA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SYRA compare to its competitors?

Compare SYRA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SYRA's performance and positioning.

What is SYRA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for SYRA with bull, base, and bear case scenarios.

What do analysts say about SYRA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SYRA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SYRA's next earnings report?

SYRA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SYRA - Syra Health Corp. Class A Common Stock

NYSE * Healthcare * Medical Care Facilities

$0.00

+$0.00 (+0.00%)

About Syra Health Corp. Class A Common Stock

Syra Health Corp. Class A Common Stock (SYRA) common stock

Price Chart

Loading chart...

SYRA Key Statistics

Market Cap

$7.22M

How SYRA Compares to Peers

SYRA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
SYRA(This stock)	$7.22M	N/A	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 16, 2026 at 9:47 AM EDT

Ready to invest in SYRA?

Commission-free trading available. Affiliate links.

SYRA Lician Score

10% confidence

5.0/10

Neutral

SYRA has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates SYRAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

SYRA Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for SYRA

Dashboard

Enter a ticker to analyze